Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 652-657

  Milgroom, Andrew ^a   Intrator, Miranda ^a   Madhavan, Krishna ^a   Mazzaro, Luciano ^a   Shandas, Robin ^a   Liu, Bolin ^b   Park, Daewon ^a  

^a University of Colorado at Denver   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Breast cancer; Contrast agent; Drug delivery; Herceptin; Mesoporous silica nanoparticles; Ultrasound

Indexed keywords

BIOCOMPATIBILITY; DISEASES; DRUG DELIVERY; MEDICAL IMAGING; MONOCLONAL ANTIBODIES; TUMORS; ULTRASONICS;

BREAST CANCER; BREAST CANCER IMAGING; CONTRAST AGENT; HERCEPTIN; IN-VITRO ASSAYS; MESOPOROUS SILICA NANOPARTICLES; REALTIME IMAGING; ULTRASOUND CONTRAST AGENT;

DIAGNOSIS;

DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESOPOROUS SILICA NANOPARTICLE; MESOPOROUS SILICA NANOPARTICLE TRASTUZUMAB CONJUGATE; NANOPARTICLE; SILICON DIOXIDE; TRASTUZUMAB; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; MONOCLONAL ANTIBODY;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL DEATH; CELL INTERACTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG SELECTIVITY; ECHOMAMMOGRAPHY; HUMAN; HUMAN CELL; IMAGE QUALITY; IN VITRO STUDY; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DIAGNOSTIC USE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ECHOGRAPHY; FEMALE; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TUMOR CELL CULTURE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL PROLIFERATION; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; NANOPARTICLES; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 84898807916     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.10.038     Document Type: Article

References (21)

1. Blair S.L., Thompson K., et al. J. Am. College Surg. 2009, 209:608.
2. Hahn M.A., Singh A.K., et al. Anal. Bioanal. Chem. 2011, 399:3.
3. Doinikov A.A., Aired L., et al. Phys. Med. Biol. 2011, 56:6951.
4. Liu T., Li L., Teng X., et al. Biomaterials 2011, 32:1657.
5. Liu J., Levine A.L., et al. Phys. Med. Biol. 2006, 51:2179.
6. Liu J., Li J., Rosol T.J., et al. Phys. Med. Biol. 2007, 52:4739.
7. Liong M., Lu J., et al. ACS Nano 2008, 2:889.
8. Casciaro S., Conversano F., et al. Invest. Radiol. 2011, 46:529.
9. Liu Y.T., Mi Y., Zhao J., et al. Int. J. Pharm. 2011, 421:370.
10. Liberman A., Martinez H.P., et al. Biomaterials 2012, 33:5124.
11. Mura S., Couvreur P. Adv. Drug Deliv. Rev. 2012, 64:1394.
12. Baum M., Buzdar A.U., et al. Lancet 2002, 359:2131.
13. Xie M., Shi H., et al. J. Coll. Inter. Sci. 2013, 395:306.
14. Chen A.M., Zhang M., et al. Small 2009, 5:2673.
15. Meng H.A., Liong M., et al. ACS Nano 2010, 4:4539.
16. Rapoport N., Gao Z.G., et al. J. Natl. Cancer Inst. 2007, 99:1095.
17. Corsetti V., Houssami N., et al. Eur. J. Cancer 2008, 44:539.
18. Chen X., Novak P., et al. Med. Phys. 2011, 38:1877.
19. Laugier P., Droin P., et al. Bone 1997, 20:157.
20. Challis R.E., Tebbutt J.S., et al. J. Phys. D-Appl. Phys. 1998, 31:3481.
21. Trewyn B.G., Nieweg J.A., et al. Chem. Eng. J. 2008, 137:23.